Accelerate Diagnostics (AXDX) Reports Q3 Loss, Lags Revenue Estimates

Accelerate Diagnostics (AXDX) came out with a quarterly loss of $0.59 per share versus the Zacks Consensus Estimate of a loss of $0.47. This compares to loss of $0.92 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -25.53%. A quarter ago, it was expected that this maker of systems that diagnose drug-resistant infections would post a loss of $0.55 per share when it actually produced a loss of $0.50, delivering a surprise of 9.0 ...